News

Fractyl Health: Speculative Buy With Binary Risk
Fractyl Health offers a high-risk, high-reward setup with a near-term binary catalyst in the REMAIN-1 cohort data expected Q3 ...
Pharmaceutical Commerce2d
The GLP-1 Gold Rush: Why Compounded Alternatives Are a Risky Bet
The intense demand for GLP-1 agonists stems from their proven efficacy in managing type 2 diabetes and, increasingly, in facilitating significant weight loss. However, patients often face substantial ...
Weight loss drugs like Ozempic may help prevent stroke and reduce brain injury-related complications, studies show
Three studies presented today at the Society of NeuroInterventional Surgery's (SNIS) 22nd Annual Meeting discussed whether ...
Ozempic ingredient linked to reduced dementia risk in diabetes patients, CWRU study shows
Case Western Reserve researchers found semaglutide users had significantly lower Alzheimer's-related dementia risk compared ...
After Falling 68%, Where Will This Weight-Loss Drug Stock Be in 2 Years? History Shows Massive Gains Ahead.
That's what happened beginning in November of last year, anyway. The company announced solid testing results for VK2735. But ...
Canadians could get more affordable version of Ozempic in early 2026. Here's how
Cheaper versions of medications to treat obesity, like Ozempic and Wegovy, could be on the market in Canada as soon as ...
Dr. Roach: Metformin can help all people, not just diabetics, lose weight
I am a 75-year-old woman who isn’t prediabetic or diabetic. My BMI is 31.2. My doctor has prescribed a trial of metformin for ...